- Home
- NYC vs NXPL Comparison
NYC vs NXPL Comparison
Compare NYC & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYC
- NXPL
- Stock Information
- Founded
- NYC 2013
- NXPL 1997
- Country
- NYC United States
- NXPL United States
- Employees
- NYC N/A
- NXPL N/A
- Industry
- NYC Real Estate
- NXPL Telecommunications Equipment
- Sector
- NYC Finance
- NXPL Telecommunications
- Exchange
- NYC Nasdaq
- NXPL Nasdaq
- Market Cap
- NYC 24.9M
- NXPL 22.8M
- IPO Year
- NYC N/A
- NXPL N/A
- Fundamental
- Price
- NYC $9.89
- NXPL $0.81
- Analyst Decision
- NYC
- NXPL
- Analyst Count
- NYC 0
- NXPL 0
- Target Price
- NYC N/A
- NXPL N/A
- AVG Volume (30 Days)
- NYC 7.6K
- NXPL 279.2K
- Earning Date
- NYC 11-11-2025
- NXPL 11-13-2025
- Dividend Yield
- NYC N/A
- NXPL N/A
- EPS Growth
- NYC N/A
- NXPL N/A
- EPS
- NYC N/A
- NXPL N/A
- Revenue
- NYC $54,865,000.00
- NXPL $58,766,000.00
- Revenue This Year
- NYC $8.40
- NXPL N/A
- Revenue Next Year
- NYC $1.62
- NXPL N/A
- P/E Ratio
- NYC N/A
- NXPL N/A
- Revenue Growth
- NYC N/A
- NXPL N/A
- 52 Week Low
- NYC $7.89
- NXPL $0.43
- 52 Week High
- NYC $16.30
- NXPL $2.30
- Technical
- Relative Strength Index (RSI)
- NYC 43.51
- NXPL 51.07
- Support Level
- NYC $9.46
- NXPL $0.77
- Resistance Level
- NYC $10.25
- NXPL $0.86
- Average True Range (ATR)
- NYC 0.64
- NXPL 0.06
- MACD
- NYC 0.09
- NXPL -0.00
- Stochastic Oscillator
- NYC 56.95
- NXPL 18.47
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.